Blastocystis laboratory diagnosis

Traditional O&P examinations / microscopy

There are numerous challenges associated with using microscopy to detect gastrointestinal parasites, which are common to most clinically relevant parasites that cause disease, including Blastocystis hominis. 

Misdiagnosis is impacted by microscopy’s low test sensitivity (<50%) due to sporadic shedding of cysts into stool, which require multiple tests on alternative days to achieve >90% test sensitivity. However, most laboratories only receive a single sample due to low patient compliance. This challenge also impacts immunoassay testing methods [1].

Blastocystis-wetmount
Blastocystis-trichrome-stain

Permanently stained slides are preferred over unstained wet-mount preparations, as the parasite is difficult to detect using wet mounts only. In addition, in wet mounts, fecal debris may be mistaken for Blastocystis spp. and vice versa [2].

Reporting of Blastocystis spp. can be problematic, as the pathogenic subtypes cannot be differentiated from non-pathogenic, when using microscopy.

Fecal immunoassays

No immunoassays are commercially available.

*Image credit: CDC website - www.cdc.gov/dpdx/blastocystis

Blastocystis parasite morphology is round and surrounded by multiple small nuclei about 6-40 µm in size.

Molecular methods for detecting Blastocystis

There are many advantages for employing molecular methods for detecting Blastocystis hominis. This includes the ability to screen for 7 other leading gastrointestinal parasites within the one test, supporting accurate and definitive identification of causative agents of parasite-associated gastrointestinal infection.

Syndromic testing for gastrointestinal parasites also supports the identification of unsuspected cases or undiagnosed cases. This is particularly important for patients with variable symptoms.

Screening of donor fecal microbiota transplantation using a molecular parasite panel would ensure that asymptomatic gastrointestinal parasite infections are detected.

 

Currently, Genetic Signatures EasyScreen Gastrointestinal Detection Kit is the only FDA (510k) cleared molecular diagnostic solution available that can detect Blastocystis hominis.

Syndromic testing for 8 gastrointestinal parasites in a single test

Up to 60 patients screened in a single, automated workflow...with same day reporting!

Genetic Signatures Syndromic workflow for detecting gastrointestinal parasites

Find out more about our unique 3base™ solution for detecting gastrointestinal parasites

3base™ advantage for parasite testing

The benefits of employing 3base™ technology for multiplex real-time PCR detection of gastrointestinal parasites

Webinars, blogs, podcasts

Leading parasitologists speak to the challenges of detecting GI parasites and the benefits of molecular testing

White papers, publications

Clinical evidence supporting the benefits of molecular testing for gastrointestinal parasites

Case studies & testimonials

Learn what industry leaders think of Genetic Signatures' novel solution for GI parasite detection

Clinically important parasites

An overview of the leading gastrointestinal parasites: Symptoms, diagnosis and treatment

References

  1. Hiatt RA, Markell EK, Ng E. How many stool examinations are necessary to detect pathogenic intestinal protozoa? The American Journal of Tropical Medicine and Hygiene. 1995 Jul;53(1):36-39. PMID: 7625530.
  2. CDC DPDx - Laboratory Identification of Parasites of Public Health Concern. Blastocystis sp. www.cdc.gov/dpdx/blastocystis/index.html